Passa al contenuto
Merck

Myelin plasticity in the ventral tegmental area is required for opioid reward.

Nature (2024-06-06)
Belgin Yalçın, Matthew B Pomrenze, Karen Malacon, Richard Drexler, Abigail E Rogers, Kiarash Shamardani, Isabelle J Chau, Kathryn R Taylor, Lijun Ni, Daniel Contreras-Esquivel, Robert C Malenka, Michelle Monje
ABSTRACT

All drugs of abuse induce long-lasting changes in synaptic transmission and neural circuit function that underlie substance-use disorders1,2. Another recently appreciated mechanism of neural circuit plasticity is mediated through activity-regulated changes in myelin that can tune circuit function and influence cognitive behaviour3-7. Here we explore the role of myelin plasticity in dopaminergic circuitry and reward learning. We demonstrate that dopaminergic neuronal activity-regulated myelin plasticity is a key modulator of dopaminergic circuit function and opioid reward. Oligodendroglial lineage cells respond to dopaminergic neuronal activity evoked by optogenetic stimulation of dopaminergic neurons, optogenetic inhibition of GABAergic neurons, or administration of morphine. These oligodendroglial changes are evident selectively within the ventral tegmental area but not along the axonal projections in the medial forebrain bundle nor within the target nucleus accumbens. Genetic blockade of oligodendrogenesis dampens dopamine release dynamics in nucleus accumbens and impairs behavioural conditioning to morphine. Taken together, these findings underscore a critical role for oligodendrogenesis in reward learning and identify dopaminergic neuronal activity-regulated myelin plasticity as an important circuit modification that is required for opioid reward.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
N-acetil-L-cisteina, BioReagent, suitable for cell culture
Sigma-Aldrich
Anticorpo anti-tirosina idrossilasi, Chemicon®, from rabbit
Sigma-Aldrich
Anticorpo anti-Aspa/Nur7, from rabbit, purified by affinity chromatography